AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Burlibact Injection

Prescription Icon
Prescription Required

Marketer

Unibiotech Formulations

Salt Composition

Ceftriaxone (1000mg)

Overview Burlibact Injection

Cephalosporin antibiotic, Burlibact Injection, combats various bacterial infections. Its applications encompass meningitis and pneumonia (brain and lung infections), alongside ear, urinary tract, skin, bone, joint, bloodstream, and heart infections. Prophylactically, it prevents surgical infections. Administered intravenously (drip) or via intramuscular/intravenous injection by a healthcare professional, dosage is determined individually. Consistent, evenly-spaced doses, as prescribed, are crucial; premature cessation risks infection recurrence or exacerbation. Common side effects – diarrhea, rash, altered liver function tests, and abnormal blood cell counts (e.g., elevated eosinophils, leukopenia, thrombocytopenia) – may occur. Injection site redness or pain is also possible. While usually mild, persistent or bothersome side effects warrant medical attention. Prior to use, disclose any antibiotic allergies, kidney or liver issues, and all other medications to your doctor, as interactions are possible.

Uses of Burlibact Injection

Managing bacterial infections

Major Benefits of Burlibact Injection:

The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Burlibact Injection:

  • Diarrhea
  • Abnormal liver function tests
  • Rash
  • Increased white blood cell count (eosinophils)
  • Decreased white blood cell count
  • Low blood platelets

How to use Burlibact Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Burlibact Injection works:

Burlibact Injection is a bacterial-killing medication. Its mechanism of action involves disrupting the synthesis of the bacteria's protective outer layer, the cell wall, thereby eliminating their viability.

SAFETY ADVICE

AlcoholAlcoholSAFE

Alcohol consumption alongside Burlibact Injection presents no known adverse reactions.

PregnancyPregnancySAFE IF PRESCRIBED

Pregnancy use of Burlibact Injection is considered safe. The majority of research indicates minimal to no fetal risk.

Breast feedingBreast feedingCAUTION

Administering Burlibact Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.

DrivingDrivingUNSAFE

Administering Burlibact Injection might reduce alertness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Burlibact Injection poses no safety concerns for patients with kidney impairment; dosage modification is unnecessary. Nevertheless, disclosure of pre-existing kidney conditions to your physician is advisable.

LiverLiverCAUTION

Patients with severe hepatic impairment should receive Burlibact Injection with close monitoring; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Burlibact Injection is unnecessary in individuals with mild or moderate liver dysfunction.

What if you forget to take Burlibact Injection :

Omit a Burlibact Injection dose? Seek your physician's advice.

Facts to Know About Burlibact Injection

LabelValue
Chemical Category Extended-Spectrum Cephalosporins (Generations 3 & 4)
Developing Habits No.
Type of Treatment Antimicrobials

FAQs on Burlibact Injection

Use Burlibact Injection only as prescribed by your doctor. Do not miss doses. Report any bothersome side effects to your doctor immediately.
Burlibact Injection typically begins working quickly, though complete bacterial eradication and symptom relief might take several days.
Do not use Burlibact Injection if you are allergic to it or its components. Inform your doctor of any liver, kidney, gallbladder, or blood disorders (including hemolytic anemia) you have or have had. Pregnant or breastfeeding individuals, or those planning pregnancy, should consult their doctor before using Burlibact Injection. Always tell your doctor about all other medications you are taking, as they may interact with Burlibact Injection.
Continue your treatment and contact your doctor if your symptoms don't improve or worsen.
Burlibact Injection typically remains in the body for approximately two days after treatment ends.
Use Burlibact Injection as prescribed by your doctor for the full course of treatment. Do not discontinue use prematurely, even if you feel better, as this may cause symptoms to recur or intensify.
Burlibact Injection must be administered by a healthcare professional; self-injection is strictly prohibited. Dosage is determined by your doctor based on your condition. For optimal results, adhere precisely to your doctor's instructions.
Burlibact Injection
70